Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tensin-3 (TNS3) is a member of the tensin family of focal adhesion proteins that physically link the actin cytoskeleton to integrin receptors at cell-matrix adhesion sites[1][3][4]. It contains N-terminal actin-binding, C-terminal Src homology 2 (SH2), and phosphotyrosine-binding (PTB) domains, allowing it to bind both actin filaments and the cytoplasmic tails of certain beta integrins[3][4]. TNS3 acts as a scaffold protein involved in cell migration, adhesion, and signal transduction, especially in response to growth factors such as EGF[1][2][4]. It regulates Rho GTPase pathways through interactions with the RhoGAP DLC1 and the GEF DOCK5, and participates in the assembly and organization of podosome belts in osteoclasts[1][2][4]. Tensin-3 supports cell proliferation, especially in mesenchymal stem cells and certain cancer cell lines[1][2]. Aberrant expression of tensin-3 is linked to cancer progression and metastasis, and it is a recently identified substrate of MALT1 protease, affecting B cell adhesion and immune functions[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tensin-3 (TNS3).